Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas Pharma
Biotech
Astellas to test out 4DMT's eye disease gene therapy vector
Astellas is putting up some cash to use one of 4D Molecular Therapeutics’ gene therapy vectors for at least one rare eye disease.
Annalee Armstrong
Jul 10, 2023 7:30pm
ASCO: Astellas exec adds gray hair with 3 pending drug approvals
Jun 7, 2023 10:50am
When ASCO dueled with Taylor Swift, we were ready for it
Jun 6, 2023 8:00am
Ex-Rubius CEO goes to Incyte—Chutes & Ladders
May 12, 2023 9:30am
Astellas inks $6B Iveric buyout ahead of FDA eye disease ruling
May 1, 2023 8:13am
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am
